{"id":1200,"date":"2025-12-05T14:38:00","date_gmt":"2025-12-05T14:38:00","guid":{"rendered":"https:\/\/retinaeyestaging.reelmedia.com.sg\/?p=1200"},"modified":"2026-06-03T13:01:13","modified_gmt":"2026-06-03T13:01:13","slug":"systemic-control-of-comorbidities-and-diabetic-retinopathy-is-there-a-link","status":"publish","type":"post","link":"https:\/\/retinaeyestaging.reelmedia.com.sg\/zh\/post\/systemic-control-of-comorbidities-and-diabetic-retinopathy-is-there-a-link\/","title":{"rendered":"\u5168\u8eab\u6027\u5e76\u53d1\u75c7\u7684\u63a7\u5236\u4e0e\u7cd6\u5c3f\u75c5\u89c6\u7f51\u819c\u75c5\u53d8\u2014\u2014\u4e8c\u8005\u4e4b\u95f4\u5b58\u5728\u5173\u8054\u5417\uff1f"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\" id=\"viewer-h1qzh15922\">Key Takeaways<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Maintaining blood sugar targets is essential, but research shows that uncontrolled blood pressure, cholesterol, and kidney dysfunction also accelerate retinal damage.<\/li>\n\n\n\n<li>Monitoring and managing multiple risk factors creates measurable improvements in eye-health outcomes, slowing disease progression.<\/li>\n\n\n\n<li>Systemic comorbidities like hypertension, dyslipidemia, and kidney disease significantly influence the development and progression of diabetic retinopathy, not just glucose levels.<\/li>\n\n\n\n<li>Lifestyle changes and multidisciplinary care enhance systemic health, which in turn supports better retinal health and visual outcomes.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-g606816175\"><a target=\"_blank\" href=\"https:\/\/www.retina-eye.co.uk\/diabetic-eye-disease-treatment\" rel=\"noreferrer noopener\"><u>Diabetic retinopathy<\/u><\/a>&nbsp;is one of the most common complications of diabetes and a leading cause of vision loss worldwide. It arises when chronic hyperglycemia damages the small blood vessels in the retina, leading to leakage, swelling, and potentially vision-threatening complications.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-zjtja13028\">While glucose control has long been the cornerstone of prevention, growing evidence shows that managing systemic comorbidities is equally important in slowing progression and reducing long-term damage.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-06xhs13030\">Understanding how these interconnected conditions influence the eyes helps patients adopt a more comprehensive approach to preserving vision.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-mt5ej13032\">How Comorbidities Influence Retinal Health<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-595bx13034\">Diabetes often occurs alongside other vascular conditions. Hypertension, dyslipidemia, and kidney disease each affect the microcirculation throughout the body\u2014including in the retina [1]. Elevated blood pressure increases mechanical stress on capillaries, making them more prone to leakage and rupture. Cholesterol abnormalities contribute to vascular plaque formation and can obstruct retinal blood flow.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-5743213036\">Kidney disease, in particular, shares similar microvascular mechanisms with retinal disease. When the glomeruli are damaged, the same process often occurs in the retinal capillaries. Studies consistently show that patients with chronic kidney disease experience faster progression of <a target=\"_blank\" href=\"https:\/\/www.retina-eye.co.uk\/diabetic-eye-disease-treatment\" rel=\"noreferrer noopener\"><u>diabetic retinopathy<\/u><\/a>, reinforcing the need to manage systemic vascular health.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-1426o13040\">Summary Table of Comorbidities and Retinal Impact<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Comorbidity<\/strong><\/td><td><strong>Effect on Retina \/ DR Progression<\/strong><\/td><td><strong>Recommended Management<\/strong><\/td><\/tr><tr><td>Hypertension<\/td><td>Increases strain on retinal microvessels; promotes microaneurysms, hemorrhages, and macular oedema<\/td><td>Blood pressure monitoring, antihypertensive medication, diet, exercise<\/td><\/tr><tr><td>Dyslipidemia<\/td><td>Leads to hard exudate formation; may impair macular function<\/td><td>Lipid profile monitoring, statins, dietary and lifestyle modifications<\/td><\/tr><tr><td>Kidney Disease<\/td><td>Microvascular damage mirrors retinal disease; accelerates progression<\/td><td>Regular kidney function tests, optimize glycemic and blood pressure control<\/td><\/tr><tr><td>Hyperglycemia<\/td><td>Damages retinal endothelial cells, stimulates inflammation and oxidative stress<\/td><td>Tight glucose control via diet, medications, and lifestyle changes<\/td><\/tr><tr><td>Smoking<\/td><td>Accelerates vascular damage; worsens DR severity<\/td><td>Smoking cessation programs<\/td><\/tr><tr><td>Obesity \/ Sedentary Lifestyle<\/td><td>Contributes to insulin resistance and vascular dysfunction<\/td><td>Weight management, regular physical activity<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-y36pa13113\">Glycemic Control: Still Foundational<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-c5x5815318\">Glucose control remains the central strategy for preventing and managing <a target=\"_blank\" href=\"https:\/\/www.retina-eye.co.uk\/diabetic-eye-disease-treatment\" rel=\"noreferrer noopener\"><u>diabetic retinopathy<\/u><\/a>. Chronic hyperglycemia damages endothelial cells, increases oxidative stress, and stimulates inflammation\u2014each contributing to retinal vessel breakdown [2]. Glucose control alone cannot fully prevent deterioration, especially when systemic comorbidities remain unmanaged.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-kfnyj13119\">Hypertension and Its Impact on the Retina<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-oq30313121\">High blood pressure is a powerful accelerant of diabetic retinopathy. Elevated systolic or diastolic pressure increases strain within retinal microvessels, promoting microaneurysm formation, hemorrhages, and macular oedema [3]. Controlling blood pressure with medication, diet, and regular monitoring significantly reduces these risks.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-fvyzi13123\">When diabetes and hypertension are managed together, the protective effect on the retina is stronger than treating either condition alone. Patients who maintain stable blood pressure experience slower progression of retinal disease and better long-term visual outcomes.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-ypn3y13125\">Hyperlipidemia: Cholesterol\u2019s Role in Retinal Damage<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-0fs2m13127\">Dyslipidemia contributes to the formation of hard exudates\u2014lipid deposits that accumulate in retinal layers [4]. These deposits can impair visual function, particularly when they affect the macula.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-o9ydd13129\">Managing cholesterol through statins, dietary modifications, and lifestyle adjustments supports healthier blood vessels and lessens the retinal impact of abnormal lipids. Effective lipid control, combined with glycemic and blood pressure management, strengthens the systemic vascular environment and lowers the risk of <a target=\"_blank\" href=\"https:\/\/www.retina-eye.co.uk\/post\/role-of-antivegf-in-proliferative-diabetic-retinopathy\" rel=\"noreferrer noopener\"><u>worsening diabetic retinopathy<\/u><\/a>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-pkr3q13133\">Kidney Disease and Retinal Outcomes<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-52xhs13135\">Diabetic nephropathy is closely linked to worsening retinal disease.&nbsp;The microvascular damage that affects kidney function mirrors the damage seen in the retina [5]. Patients with declining kidney function experience higher rates of <a target=\"_blank\" href=\"https:\/\/www.retina-eye.co.uk\/post\/how-often-and-why-should-you-get-screened-for-diabetic-retinopathy\" rel=\"noreferrer noopener\"><u>advanced diabetic retinopathy<\/u><\/a>, including proliferative changes and macular oedema.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-0eto513141\">Early detection of kidney disease\u2014through regular monitoring of urine albumin, creatinine, and estimated glomerular filtration rate\u2014allows timely interventions. When kidney health improves or stabilizes, retinal outcomes often improve as well, highlighting the importance of systemic care.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-ad7g213143\">Lifestyle Interventions and Their Protective Effects<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-dt4b113145\">Lifestyle modification remains a critical aspect of systemic risk reduction. Regular physical activity improves cardiovascular function, enhances insulin sensitivity, and supports retinal perfusion. A balanced diet rich in whole foods, healthy fats, and limited processed sugars promotes better glucose, lipid, and blood pressure control [6].<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-637uf13147\">Smoking cessation is especially important. Tobacco use accelerates vascular damage and increases the <a target=\"_blank\" href=\"https:\/\/www.retina-eye.co.uk\/post\/munjaro-ozempic-and-diabetic-retinopathy\/\" rel=\"noreferrer noopener\"><u>severity of diabetic retinopathy<\/u><\/a>. Weight management further supports metabolic stability, reducing the burden on retinal microcirculation.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-o14i313151\">Medication Management and Team-Based Care<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-qizem13153\">Controlling comorbidities usually requires a combination of medications\u2014such as antihypertensives, statins, and agents that protect kidney function. Adherence to treatment is crucial for maintaining stable systemic health, which directly influences retinal outcomes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-andg713155\">A multidisciplinary care model significantly improves overall management. Collaboration among endocrinologists, nephrologists, primary care physicians, and ophthalmologists provides cohesive care plans that address both systemic disease and the ocular complications of diabetes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-fsic413157\">This coordinated approach ensures that <a target=\"_blank\" href=\"https:\/\/www.retina-eye.co.uk\/diabetic-eye-disease-treatment\" rel=\"noreferrer noopener\"><u>diabetic retinopathy<\/u><\/a>&nbsp;is not treated in isolation but as part of a broader health picture.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-lkkv913161\">Monitoring and Regular Eye Exams<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-ybii413163\">Even with excellent systemic control, regular retinal evaluations remain essential. Comprehensive eye exams\u2014especially those including fundus photography and optical coherence tomography\u2014allow early identification of subtle retinal changes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-7u7zi13165\">Patients with multiple uncontrolled comorbidities may require more frequent monitoring. Early detection allows timely initiation of treatments such as laser therapy or anti-VEGF injections, reducing the risk of permanent visual impairment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-wrljl13167\">Synergistic Benefits of Systemic Health<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-7ygdz13169\">Improved systemic health produces synergistic benefits across multiple organs. When blood glucose, blood pressure, and cholesterol are well controlled, the risk of cardiovascular events declines, kidney health stabilizes, and the retina receives better oxygenation and blood flow.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-dwo7013171\">This holistic approach enhances the effectiveness of ocular treatments and reduces long-term complications. The stability of systemic health directly influences the trajectory of diabetic retinopathy.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-aaw4n13173\">Educating and Empowering Patients<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-v3g4o13175\">Patient understanding is essential for long-term disease management. When individuals recognize how systemic factors influence their eyes, they are more likely to adhere to medication, lifestyle adjustments, and follow-up schedules.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-bl7it13177\">Support groups and educational programs help patients navigate complex medical decisions and maintain motivation. Empowering patients strengthens engagement and improves both systemic outcomes and rates of progression for diabetic retinopathy.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-mkxbj13179\">Conclusion<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-2nf5j13181\">There is a clear connection between systemic health and the course of diabetic retinopathy. Effective management of blood sugar, blood pressure, lipids, and kidney function significantly reduces the risk of vision loss and improves overall wellness.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-5xb8j13183\">Multidisciplinary care, lifestyle changes, medication adherence, and regular retinal exams create a comprehensive approach that protects long-term vision. By addressing diabetes and its related comorbidities together, patients can slow disease progression, maintain independence, and safeguard their vision for years to come.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-syijn13185\">References<\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Wong, T. Y., &amp; Cheung, C. M. G. (2016). Associations between diabetic retinopathy and systemic vascular risk factors. <em>The Lancet Diabetes &amp; Endocrinology, 4<\/em>(5), 389\u2013400.<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27779095\/\" target=\"_blank\" rel=\"noreferrer noopener\"><u>\u00a0<\/u><\/a><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27779095\/\" target=\"_blank\" rel=\"noreferrer noopener\"><u>https:\/\/pubmed.ncbi.nlm.nih.gov\/27779095\/<\/u><\/a><\/li>\n\n\n\n<li>Antonetti, D. A., Klein, R., &amp; Gardner, T. W. (2012). Diabetic retinopathy. <em>New England Journal of Medicine, 366<\/em>, 1227\u20131239.<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5432556\/\" target=\"_blank\" rel=\"noreferrer noopener\"><u>\u00a0<\/u><\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5432556\/\" target=\"_blank\" rel=\"noreferrer noopener\"><u>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5432556\/<\/u><\/a><\/li>\n\n\n\n<li>StatPearls. (2025). Diabetic retinopathy. <em>StatPearls Publishing.<\/em><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560805\/\" target=\"_blank\" rel=\"noreferrer noopener\"><u>\u00a0<\/u><\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560805\/\" target=\"_blank\" rel=\"noreferrer noopener\"><u>https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560805\/<\/u><\/a><\/li>\n\n\n\n<li>Li, Z., Yuan, Y., Qi, Q., et al. (2023). Relationship between dyslipidemia and diabetic retinopathy in type 2 diabetes mellitus: A systematic review and meta\u2011analysis. <em>Systematic Reviews, 12<\/em>, 148.<a href=\"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-023-02321-2\" target=\"_blank\" rel=\"noreferrer noopener\"><u>\u00a0<\/u><\/a><a href=\"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-023-02321-2\" target=\"_blank\" rel=\"noreferrer noopener\"><u>https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-023-02321-2<\/u><\/a><\/li>\n\n\n\n<li>Sun, H., Yan, L., &amp; Liu, W. (2024). The relationship between diabetic retinopathy and diabetic nephropathy in type 2 diabetes. <em>PubMed.<\/em><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38344659\/\" target=\"_blank\" rel=\"noreferrer noopener\"><u>\u00a0<\/u><\/a><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38344659\/\" target=\"_blank\" rel=\"noreferrer noopener\"><u>https:\/\/pubmed.ncbi.nlm.nih.gov\/38344659\/<\/u><\/a><\/li>\n\n\n\n<li>Hove, M., &amp; R\u00f8der, M. E. (2022). Lifestyle interventions for prevention and management of diabetic retinopathy. <em>Diabetes &amp; Metabolism Journal, 46<\/em>(6), 783\u2013795.<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9722205\/\" target=\"_blank\" rel=\"noreferrer noopener\"><u>\u00a0<\/u><\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9722205\/\" target=\"_blank\" rel=\"noreferrer noopener\"><u>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9722205\/<\/u><\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Diabetic retinopathy&nbsp;is one of the most common complications of diabetes and a leading cause of vision loss worldwide. It arises when chronic hyperglycemia damages the small blood vessels in the retina, leading to leakage, swelling, and potentially vision-threatening complications.&nbsp; While glucose control has long been the cornerstone of prevention, growing evidence shows that [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2320,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[9],"tags":[],"class_list":["post-1200","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/retinaeyestaging.reelmedia.com.sg\/zh\/wp-json\/wp\/v2\/posts\/1200","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/retinaeyestaging.reelmedia.com.sg\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/retinaeyestaging.reelmedia.com.sg\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/retinaeyestaging.reelmedia.com.sg\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/retinaeyestaging.reelmedia.com.sg\/zh\/wp-json\/wp\/v2\/comments?post=1200"}],"version-history":[{"count":1,"href":"https:\/\/retinaeyestaging.reelmedia.com.sg\/zh\/wp-json\/wp\/v2\/posts\/1200\/revisions"}],"predecessor-version":[{"id":1202,"href":"https:\/\/retinaeyestaging.reelmedia.com.sg\/zh\/wp-json\/wp\/v2\/posts\/1200\/revisions\/1202"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/retinaeyestaging.reelmedia.com.sg\/zh\/wp-json\/wp\/v2\/media\/2320"}],"wp:attachment":[{"href":"https:\/\/retinaeyestaging.reelmedia.com.sg\/zh\/wp-json\/wp\/v2\/media?parent=1200"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/retinaeyestaging.reelmedia.com.sg\/zh\/wp-json\/wp\/v2\/categories?post=1200"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/retinaeyestaging.reelmedia.com.sg\/zh\/wp-json\/wp\/v2\/tags?post=1200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}